Physician
Jacobson, Janet
Jacobson, Janet was paid $5.12M by Medicaid between Jan 2018 and Aug 2023, across 47 billing codes. Its largest line is J7307, Etonogestrel (contraceptive) implant system, including implant and supplies — 24% of everything it billed.
33Billing provider infoJACOBSON, JANET
ORANGE, CA 92866
ORANGE, CA 92866
33aNPI1164578795assigned 01/26/2007
33bProvider typeObstetrics & Gynecology Physician
28Total paid$5.12M
24GClaims101,242
24DCodes billed47
24AFirst – last monthJan 2018 – Aug 2023
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in California
Rank by total paid#24 of 791
Median peer was paid$67K
This provider vs. median77×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,332 | $1.78M | |
| 2019 | 17,860 | $899K | |
| 2020 | 10,905 | $502K | |
| 2021 | 21,765 | $1.06M | |
| 2022 | 16,754 | $697K | |
| 2023 | 4,626 | $174K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 24% | 1,520 | 1,487 | $1.24M |
| S4993 | Contraceptive pills for birth control | 13% | 3,812 | 3,761 | $648K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 7.9% | 10,368 | 10,252 | $402K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 7.7% | 10,361 | 10,247 | $394K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 6.2% | 5,002 | 4,476 | $316K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.8% | 5,979 | 4,952 | $243K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 4.3% | 3,257 | 3,119 | $221K |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 4.1% | 356 | 349 | $210K |
| J7304 | Contraceptive supply, hormone containing patch, each | 3.2% | 197 | 193 | $165K |
| J3490 | Unclassified drugs | 3.0% | 6,416 | 6,178 | $156K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 2.7% | 1,963 | 1,644 | $139K |
| A4267 | Contraceptive supply, condom, male, each | 2.0% | 8,783 | 8,545 | $101K |
35 more codes
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 1.8% | 103 | $94K |
| 87806 | 1.7% | 3,394 | $86K | |
| 58300 | 1.6% | 906 | $82K | |
| 11981 | 1.6% | 466 | $82K | |
| 90651 | 1.3% | 298 | $64K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.2% | 2,143 | $63K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 2,165 | $48K |
| 81025 | <1% | 13,804 | $43K | |
| 11976 | <1% | 726 | $41K | |
| 59840 | <1% | 150 | $37K | |
| 57454 | <1% | 512 | $34K | |
| S0190 | Mifepristone, oral, 200 mg | <1% | 468 | $30K |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 41 | $28K |
| 99243 | <1% | 289 | $19K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 238 | $15K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 143 | $15K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 311 | $14K |
| 90674 | <1% | 423 | $14K | |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | <1% | 76 | $13K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | <1% | 2,920 | $12K |
| 83986 | <1% | 2,922 | $10K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 474 | $9K |
| 99000 | <1% | 3,378 | $9K | |
| 58301 | <1% | 297 | $9K | |
| Q3014 | Telehealth originating site facility fee | <1% | 214 | $5K |
| 81002 | <1% | 1,123 | $3K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 381 | $2K |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 527 | $2K |
| 85018 | <1% | 514 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 448 | $799.46 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 140 | $743.99 |
| S0197 | Prenatal vitamins, 30-day supply | <1% | 205 | $229.83 |
| 86901 | <1% | 93 | $209.75 | |
| S5000 | Prescription drug, generic | <1% | 2,427 | $8.00 |
| S5001 | Prescription drug, brand name | <1% | 509 | $2.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.